Advisor Group Holdings, Inc. Meridian Bioscience Inc Transaction History

Advisor Group Holdings, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$31.15 - $33.39 $36,570 - $39,199	-1,174 Reduced 13.64%	7,433 $246,000
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $1.28 Million - $1.39 Million	-41,497 Reduced 82.82%	8,607 $272,000
Q2 2022 Aug 10, 2022	BUY	$23.75 - $31.69 $799,211 - $1.07 Million	33,651 Added 204.53%	50,104 $1.52 Million
Q1 2022 May 04, 2022	BUY	$19.97 - $26.94 $6,849 - $9,240	343 Added 2.13%	16,453 $464,000
Q3 2021 Nov 05, 2021	SELL	$17.35 - $22.5 $24,411 - $31,657	-1,407 Reduced 8.03%	16,110 $310,000
Q2 2021 Aug 02, 2021	SELL	$18.01 - $28.32 $254,697 - $400,501	-14,142 Reduced 44.67%	17,517 $388,000
Q1 2021 May 13, 2021	BUY	$19.76 - $29.89 $349,613 - $528,843	17,693 Added 126.69%	31,659 $831,000
Q4 2020 Feb 10, 2021	BUY	$15.73 - $21.66 $28,314 - $38,988	1,800 Added 14.8%	13,966 $261,000
Q3 2020 Nov 12, 2020	BUY	$13.54 - $26.41 $139,001 - $271,125	10,266 Added 540.32%	12,166 $207,000
Q2 2020 Aug 14, 2020	BUY	$7.84 - $23.29 $3,136 - $9,316	400 Added 26.67%	1,900 $44,000
Q1 2020 May 18, 2020	BUY	$5.57 - $11.5 $8,355 - $17,250	1,500 New	1,500 $13,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.